0
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found

      Radioimmunoassay for Human Pituitary Prolactin, Using Antiserum against an Extract of Human Amniotic Fluid

      ,

      Hormone Research in Paediatrics

      S. Karger AG

      Amniotic fluid, Prolactin, Radioimmunoassay, Human

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Rabbit antiserum raised against a prolactin-rich extract of human amniotic fluid was used to establish a double-antibody radioimmunoassay for human pituitary prolactin inplasma. The binding of <sup>131</sup>I-labelIed human pituitary prolactin(Lewis) to the antiserum was inhibited by unlabelled prolactin, human chorionic gonadotrophin (HCG), human luteinizing hormone (HLH) and human follicle stimulating hormone (HFSH). Absorption of the antiserum with HCG rendered the assay specific for prolactin no cross-reaction being then observed with HLH, HFSH, human thyroid stimulating hormone, human growth hormone or human chorionic somatomammotrophin. The binding of <sup>131</sup>I-labelled human pituitary prolactin (Friesen) to antibody was not affected by HCG. The concentration of prolactin in plasmas from normal males, pregnant females, non-pregnant females and in patients treated with phenothiazine was measured.

          Related collections

          Author and article information

          Journal
          HRE
          Horm Res Paediatr
          10.1159/issn.1663-2818
          Hormone Research in Paediatrics
          S. Karger AG
          1663-2818
          1663-2826
          1973
          1973
          21 November 2008
          : 4
          : 5
          : 261-273
          Affiliations
          Tenovus Institute for Cancer Research and Department of Chemical Pathology, Welsh National School of Medicine, Cardiff
          Article
          178313 Horm Res 1973;4:261–273
          10.1159/000178313
          4796385
          © 1973 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          Page count
          Pages: 13
          Categories
          Paper

          Comments

          Comment on this article